| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1292530
[patent_doc_number] => 06630579
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-10-07
[patent_title] => 'Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use'
[patent_app_type] => B2
[patent_app_number] => 09/740991
[patent_app_country] => US
[patent_app_date] => 2000-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7208
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/630/06630579.pdf
[firstpage_image] =>[orig_patent_app_number] => 09740991
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/740991 | Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use | Dec 20, 2000 | Issued |
| 09/702876 | Pyrimidine nucleotide precursors for tratment of systemic inflammation and inflammatory hepatitis | Oct 31, 2000 | Abandoned |
Array
(
[id] => 1233393
[patent_doc_number] => RE038416
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2004-02-03
[patent_title] => 'Cross-linking oligonucleotides'
[patent_app_type] => E1
[patent_app_number] => 09/693213
[patent_app_country] => US
[patent_app_date] => 2000-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11525
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/038/RE038416.pdf
[firstpage_image] =>[orig_patent_app_number] => 09693213
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/693213 | Cross-linking oligonucleotides | Oct 18, 2000 | Issued |
Array
(
[id] => 1253533
[patent_doc_number] => 06670341
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-30
[patent_title] => 'Compositions and methods for double-targeting virus infections and targeting cancer cells'
[patent_app_type] => B1
[patent_app_number] => 09/693658
[patent_app_country] => US
[patent_app_date] => 2000-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 19238
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 330
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/670/06670341.pdf
[firstpage_image] =>[orig_patent_app_number] => 09693658
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/693658 | Compositions and methods for double-targeting virus infections and targeting cancer cells | Oct 18, 2000 | Issued |
| 09/624855 | Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated t-lymphocytes | Jul 24, 2000 | Abandoned |
Array
(
[id] => 1340879
[patent_doc_number] => 06589942
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-08
[patent_title] => 'Chitosan metal complexes and method for controlling microbial growth on plants using same'
[patent_app_type] => B1
[patent_app_number] => 09/621915
[patent_app_country] => US
[patent_app_date] => 2000-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2966
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/589/06589942.pdf
[firstpage_image] =>[orig_patent_app_number] => 09621915
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/621915 | Chitosan metal complexes and method for controlling microbial growth on plants using same | Jul 23, 2000 | Issued |
Array
(
[id] => 1334916
[patent_doc_number] => 06596859
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-22
[patent_title] => 'Process to prepare pyrimidine nucleosides'
[patent_app_type] => B1
[patent_app_number] => 09/618780
[patent_app_country] => US
[patent_app_date] => 2000-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2554
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 219
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/596/06596859.pdf
[firstpage_image] =>[orig_patent_app_number] => 09618780
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/618780 | Process to prepare pyrimidine nucleosides | Jul 17, 2000 | Issued |
Array
(
[id] => 990919
[patent_doc_number] => 06919446
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-07-19
[patent_title] => 'Reduced malto-oligosaccharides'
[patent_app_type] => utility
[patent_app_number] => 09/614961
[patent_app_country] => US
[patent_app_date] => 2000-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5596
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/919/06919446.pdf
[firstpage_image] =>[orig_patent_app_number] => 09614961
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/614961 | Reduced malto-oligosaccharides | Jul 12, 2000 | Issued |
Array
(
[id] => 1401304
[patent_doc_number] => 06531591
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-11
[patent_title] => 'Synthesis of stable quinone and photoreactive ketone phosphoramidite reagents for solid phase synthesis of photoreactive-oligomer conjugates'
[patent_app_type] => B1
[patent_app_number] => 09/611833
[patent_app_country] => US
[patent_app_date] => 2000-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8214
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/531/06531591.pdf
[firstpage_image] =>[orig_patent_app_number] => 09611833
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/611833 | Synthesis of stable quinone and photoreactive ketone phosphoramidite reagents for solid phase synthesis of photoreactive-oligomer conjugates | Jul 6, 2000 | Issued |
Array
(
[id] => 1312815
[patent_doc_number] => 06613896
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-02
[patent_title] => 'Method of producing tiazofurin and other C-nucleosides'
[patent_app_type] => B1
[patent_app_number] => 09/445713
[patent_app_country] => US
[patent_app_date] => 2000-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4736
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/613/06613896.pdf
[firstpage_image] =>[orig_patent_app_number] => 09445713
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/445713 | Method of producing tiazofurin and other C-nucleosides | Jun 5, 2000 | Issued |
| 09/580089 | Methods for inhibiting angiogenesis with combretastatin A-4 | May 29, 2000 | Abandoned |
Array
(
[id] => 1046848
[patent_doc_number] => 06864243
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-08
[patent_title] => 'Method for treating retinal degeneration with purinergic receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 09/570231
[patent_app_country] => US
[patent_app_date] => 2000-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8274
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/864/06864243.pdf
[firstpage_image] =>[orig_patent_app_number] => 09570231
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/570231 | Method for treating retinal degeneration with purinergic receptor agonists | May 11, 2000 | Issued |
Array
(
[id] => 1400755
[patent_doc_number] => 06537975
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-25
[patent_title] => 'Aryl phosphate derivatives of d4T having anti-HIV activity'
[patent_app_type] => B1
[patent_app_number] => 09/548496
[patent_app_country] => US
[patent_app_date] => 2000-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 9493
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/537/06537975.pdf
[firstpage_image] =>[orig_patent_app_number] => 09548496
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/548496 | Aryl phosphate derivatives of d4T having anti-HIV activity | Apr 12, 2000 | Issued |
Array
(
[id] => 1253525
[patent_doc_number] => 06670336
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-30
[patent_title] => 'Aryl phosphate derivatives of d4T having anti-HIV activity'
[patent_app_type] => B1
[patent_app_number] => 09/548494
[patent_app_country] => US
[patent_app_date] => 2000-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 9338
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/670/06670336.pdf
[firstpage_image] =>[orig_patent_app_number] => 09548494
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/548494 | Aryl phosphate derivatives of d4T having anti-HIV activity | Apr 12, 2000 | Issued |
Array
(
[id] => 1411420
[patent_doc_number] => 06528495
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-04
[patent_title] => 'Aryl phosphate derivatives of d4T having anti-HIV activity'
[patent_app_type] => B1
[patent_app_number] => 09/548492
[patent_app_country] => US
[patent_app_date] => 2000-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 9509
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/528/06528495.pdf
[firstpage_image] =>[orig_patent_app_number] => 09548492
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/548492 | Aryl phosphate derivatives of d4T having anti-HIV activity | Apr 12, 2000 | Issued |
Array
(
[id] => 788193
[patent_doc_number] => 06987125
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-01-17
[patent_title] => 'Compositions and methods of treating, reducing and preventing cardiovascular diseases and disorders with polymethoxyflavones'
[patent_app_type] => utility
[patent_app_number] => 09/528488
[patent_app_country] => US
[patent_app_date] => 2000-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4329
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/987/06987125.pdf
[firstpage_image] =>[orig_patent_app_number] => 09528488
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/528488 | Compositions and methods of treating, reducing and preventing cardiovascular diseases and disorders with polymethoxyflavones | Mar 16, 2000 | Issued |
Array
(
[id] => 935246
[patent_doc_number] => 06974595
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-12-13
[patent_title] => 'Pharmaceutical compositions based on Diclofenae'
[patent_app_type] => utility
[patent_app_number] => 09/524747
[patent_app_country] => US
[patent_app_date] => 2000-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5157
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/974/06974595.pdf
[firstpage_image] =>[orig_patent_app_number] => 09524747
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/524747 | Pharmaceutical compositions based on Diclofenae | Mar 13, 2000 | Issued |
Array
(
[id] => 7612612
[patent_doc_number] => 06903223
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-06-07
[patent_title] => 'Phenyldiazirine compounds and photoaffinity labeling reagent'
[patent_app_type] => utility
[patent_app_number] => 09/519880
[patent_app_country] => US
[patent_app_date] => 2000-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10989
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/903/06903223.pdf
[firstpage_image] =>[orig_patent_app_number] => 09519880
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/519880 | Phenyldiazirine compounds and photoaffinity labeling reagent | Mar 5, 2000 | Issued |
Array
(
[id] => 1344790
[patent_doc_number] => 06586589
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-01
[patent_title] => 'Process for treating alginic acid to produce polyguluronic acids or concentrated solutions for use in producing polyguluronic acids'
[patent_app_type] => B1
[patent_app_number] => 09/513639
[patent_app_country] => US
[patent_app_date] => 2000-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5855
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/586/06586589.pdf
[firstpage_image] =>[orig_patent_app_number] => 09513639
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/513639 | Process for treating alginic acid to produce polyguluronic acids or concentrated solutions for use in producing polyguluronic acids | Feb 24, 2000 | Issued |
Array
(
[id] => 1312809
[patent_doc_number] => 06613895
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-02
[patent_title] => 'System and methods for the rapid isolation of nucleic acids'
[patent_app_type] => B1
[patent_app_number] => 09/510563
[patent_app_country] => US
[patent_app_date] => 2000-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 8930
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/613/06613895.pdf
[firstpage_image] =>[orig_patent_app_number] => 09510563
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/510563 | System and methods for the rapid isolation of nucleic acids | Feb 21, 2000 | Issued |